Publications 2006

Al Najjar, A., I. Etienne, P. Le Pogamp, F. Bridoux, Y. Le Meur, O. Toupance, C. Mousson, S. Caillard, B. H. de Ligny, J. F. Marliere, and Y. Lebranchu. 2006. Long-term results of monoclonal anti-il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation. Transplant Proc 38:2298.

Buchler, M. , A. Bretagnol, C. Desaldeleer, P. Garreau, J. M. Halimi, A. Al-Najjar, J. F. Marliere, H. Nivet, and Y. Lebranchu. 2006. Estimation of the glomerular filtration rate through different methods in kidney transplant recipients: correlation with the creatinine clearance measurement. Transplant Proc 38:2289.

Buchler, M. , S. Chadban, E. Cole, K. Midtvedt, E. Thervet, H. Prestele, and P. Keown. 2006. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases. Nephrol Dial Transplant 21:197;

Chapman, J., A. Bock, B. Dussol, L. Fritsche, V. Kliem, Y. Lebranchu, F. Oppenheimer, E. Pohanka, M. Salvadori, and G. Tufveson. 2006. Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int 19:715;

Choquet, S., V. Leblond, R. Herbrecht, G. Socie, A. M. Stoppa, P. Vandenberghe, A. Fischer, F. Morschhauser, G. Salles, W. Feremans, E. Vilmer, M. N. Peraldi, P. Lang, Y. Lebranchu, E. Oksenhendler, J. L. Garnier, T. Lamy, A. Jaccard, A. Ferrant, F. Offner, O. Hermine, A. Moreau, S. Fafi-Kremer, P. Morand, L. Chatenoud, N. Berriot-Varoqueaux, L. Bergougnoux, and N. Milpied. 2006. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 107:3053;

Halimi, J., I. Laouad, M. Buchler, A. Al-Najjar, V. Chatelet, T. S. Houssaini, H. Nivet, and Y. Lebranchu. 2006. Early Proteinuria Is a Strong Indicator of Donor Renal Lesions, Ischemia-Reperfusion Injury and Immunological Aggression. Transplant Proc 38:2319.

Halimi, J. M., A. Al-Najjar, M. Buchler, and I. Laouad. 2006. Nephron dosing and proteinuria. Am J Transplant 6:1495; Salvadori, M., A. Rosati, E. Bertoni, A. Bock, J. Chapman, B. Dussol, L. Fritsche, V. Kliem, Y. Lebranchu, F. Oppenheimer, E. Pohanka, G. Tufveson, and M. Soergel. 2006. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study. Transplant Proc 38:1010;

Salvadori, M., A. Rosati, A. Bock, J. Chapman, B. Dussol, L. Fritsche, V. Kliem, Y. Lebranchu, F. Oppenheimer, E. Pohanka, G. Tufveson, and E. Bertoni. 2006. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 81:202;

Vargas-Poussou, R., P. Houillier, N. Le Pottier, L. Strompf, C. Loirat, V. Baudouin, M. A. Macher, M. Dechaux, T. Ulinski, F. Nobili, P. Eckart, R. Novo, M. Cailliez, R. Salomon, H. Nivet, P. Cochat, I. Tack, A. Fargeot, F. Bouissou, G. R. Kesler, S. Lorotte, N. Godefroid, V. Layet, G. Morin, X. Jeunemaitre, and A. Blanchard. 2006. Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J Am Soc Nephrol 17:1437;

Hoarau, C., C. Lagaraine, L. Martin, F. Velge-Roussel, and Y. Lebranchu. 2006. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 117:696;